Long-term study of SHR-1918 for homozygous familial hypercholesterolemia
Treatments studied
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests the long-term safety and effectiveness of the drug SHR-1918. It is for people with homozygous familial hypercholesterolemia who have already benefited from this drug in a previous study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have taken part in the earlier SHR-1918-301 study and completed the treatment.
- Your doctors must have decided that you got benefit from the treatment in that study.
- You cannot be allergic to SHR-1918 or any of its ingredients.
- You must not have had cancer in the last 5 years.
- You cannot have any serious medical conditions that could interfere with the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a one-time gene therapy (NGGT006) to treat a severe form of inherited high cholesterol that doesn't respond well to standard medications. It aims to lower cholesterol and reduce the risk of heart disease.
This trial is a registry that collects information from people with homozygous familial hypercholesterolemia (an inherited condition causing extremely high “bad” cholesterol). It may help researchers better understand the condition and support future studies.
This study tests a new injectable medication (SYH2070) designed to lower cholesterol in people with homozygous familial hypercholesterolemia—a genetic condition that causes extremely high cholesterol levels despite treatment. The goal is to see if this drug safely reduces cholesterol better than current options.
This trial tests a new medicine, SHR-1918, for people whose bad cholesterol (LDL-C) stays high even when they take statins and another type of cholesterol-lowering drug called a PCSK9 inhibitor. It aims to see if this additional treatment can lower their cholesterol more effectively.
This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.
This trial tests a new medication called SHR-1918 for people with high cholesterol who are already on statins. The goal is to see if it can further lower cholesterol and improve health.
Hear when a new Homozygous Familial Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.